BioMarin to Discuss Q3 2025 Results and Business Highlights
BioMarin Financial Results Conference Call Scheduled
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is set to host a conference call and webcast to discuss its third quarter 2025 financial results. The event is scheduled for the evening of October 27, 2025, at 4:30 PM ET, led by Alexander Hardy, the President and CEO of BioMarin.
Details of the Call
Participants can join the call using the following dial-in numbers:
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 4998437
For those unable to attend live, there will be a replay available. The U.S. / Canada replay dial-in number is 800-770-2030, and the international replay number is 609-800-9909. The Playback ID for replay will also be 4998437.
How to Access the Webcast
A live audio webcast of the conference call can be accessed via the investor section of the BioMarin website. This audio resource will be accessible for one week following the call for those wishing to catch up on the insights shared.
About BioMarin
Founded in 1997 and headquartered in San Rafael, California, BioMarin is a pioneering biotechnology firm focused on transforming genetic discoveries into impactful therapies. The company is recognized for its innovative spirit, having developed eight commercial therapies and maintaining a robust pipeline of clinical and preclinical projects.
Commitment to Patients
BioMarin's commitment to addressing rare and difficult-to-treat genetic disorders is at the core of its mission. The initiatives undertaken aim to offer new solutions for patients and families confronting challenging health conditions.
Investor and Media Contacts
For more inquiries, interested parties can contact the following individuals:
Investors: Traci McCarty of BioMarin Pharmaceutical Inc. at (415) 455-7558
Media: Marni Kottle of BioMarin also available at (650) 374-2803
Frequently Asked Questions
What is the date and time of BioMarin's conference call?
The conference call is scheduled for October 27, 2025, at 4:30 PM ET.
Who will be hosting the call?
Alexander Hardy, the President and Chief Executive Officer of BioMarin, will lead the call.
How can I join the conference call?
You can join the call by dialing the U.S. or international numbers provided or by accessing the live audio webcast on the BioMarin website.
Is there a replay option for the conference call?
Yes, a replay will be available for one week after the call.
What does BioMarin focus on?
BioMarin is dedicated to creating therapies for patients with rare or difficult-to-treat genetic conditions, showcasing a strong commitment to innovation in biotechnology.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.